Logo image
Viral resistance of MOGS-CDG patients implies a broad-spectrum strategy against acute virus infections
Journal article   Open access   Peer reviewed

Viral resistance of MOGS-CDG patients implies a broad-spectrum strategy against acute virus infections

Jinhong Chang, Timothy M. Block and Ju-Tao Guo
Antiviral therapy, v 20(3)
01 Jan 2015
PMID: 25318123
url
https://europepmc.org/articles/pmc4446249View
Accepted (AM)Open Access (License Unspecified) Open

Abstract

Infectious Diseases Life Sciences & Biomedicine Pharmacology & Pharmacy Science & Technology Virology
Sadat et al. reported in the 24 April 2014 issue of the New England Journal of Medicine that patients genetically deficient in the gene encoding mannosyl-oligosaccharide glucosidase (MOGS), also known as endoplasmic reticulum (ER) glucosidase I, manifested a severe hypogammaglobulinaemia without clinical evidence of an infectious diathesis. This paradox phenomenon is, at least in part, because the impaired N-linked glycan processing of the patients compromises their ability to support efficient replication and cellular entry of viruses. This finding unambiguously validates ER glucosidases as valuable targets for antiviral agents against a broad-spectrum of enveloped viruses.

Metrics

10 Record Views
18 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Infectious Diseases
Pharmacology & Pharmacy
Virology
Logo image